发明名称 PHARMACEUTICAL COMPOSITIONS COMPRISINGN HYDROMORPHONE AND NALOXONE
摘要 <p>There is described a prolonged release pharmaceutical dosage form comprising a plurality of coated beads, each of the coated beads comprising: (a) a granule; (b) a first layer coated on the granule, the first layer comprising: (i) hydromorphone or a pharmaceutically acceptable salt thereof, (ii) naloxone or a pharmaceutically acceptable salt thereof, (iii) an antioxidant compound, and (iii) a chelating compound; and (c) a second layer coated on the first layer, the second layer comprising a prolonged release agent. The dosage form has improved stability and dissolution properties. Another aspect of the invention relates to use of a combination of an antioxidant (such as sodium metabisulfite) and a chelating agent (such as ethylenedinitrotetraacetic acid disodium salt dihydrate) to improve the stability and/or dissolution properties of a prolonged release dosage form comprising (i) hydromorphone or a pharmaceutically acceptable salt thereof and (ii) naloxone or a pharmaceutically acceptable salt thereof.</p>
申请公布号 CA2795324(A1) 申请公布日期 2014.05.09
申请号 CA20122795324 申请日期 2012.11.09
申请人 PURDUE PHARMA 发明人 VARGAS RINCON, RICARDO ALBERTO
分类号 A61K47/18;A61K9/16;A61K9/52;A61K31/485;A61K47/02 主分类号 A61K47/18
代理机构 代理人
主权项
地址